Private Capital Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-913
| Closed | -$168K | – | 2243 |
|
2021
Q2 | $168K | Sell |
913
-130
| -12% | -$23.9K | 0.04% | 262 |
|
2021
Q1 | $159K | Sell |
1,043
-1,122
| -52% | -$171K | 0.04% | 258 |
|
2020
Q4 | $338K | Sell |
2,165
-1,109
| -34% | -$173K | 0.06% | 213 |
|
2020
Q3 | $375K | Sell |
3,274
-267
| -8% | -$30.6K | 0.08% | 171 |
|
2020
Q2 | $397K | Buy |
3,541
+306
| +9% | +$34.3K | 0.09% | 163 |
|
2020
Q1 | $290K | Buy |
3,235
+827
| +34% | +$74.1K | 0.08% | 183 |
|
2019
Q4 | $260K | Buy |
2,408
+460
| +24% | +$49.7K | 0.06% | 216 |
|
2019
Q3 | $191K | Sell |
1,948
-476
| -20% | -$46.7K | 0.03% | 305 |
|
2019
Q2 | $301K | Buy |
2,424
+12
| +0.5% | +$1.49K | 0.07% | 171 |
|
2019
Q1 | $326K | Hold |
2,412
| – | – | 0.06% | 187 |
|
2018
Q4 | $235K | Sell |
2,412
-26
| -1% | -$2.53K | 0.05% | 211 |
|
2018
Q3 | $338K | Buy |
2,438
+14
| +0.6% | +$1.94K | 0.07% | 180 |
|
2018
Q2 | $300K | Sell |
2,424
-12
| -0.5% | -$1.49K | 0.06% | 182 |
|
2018
Q1 | $272K | Sell |
2,436
-458
| -16% | -$51.1K | 0.06% | 198 |
|
2017
Q4 | $346 | Buy |
+2,894
| New | +$346 | 0.08% | 160 |
|